Provenance du réseau au premier degré de Roger Belusa
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Roger Belusa via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABLYNX | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Antwerp | College/University | Doctorate Degree | |
Highlight Therapeutics SL
 Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree |
Statistiques
Internationale
| Belgique | 4 |
| Espagne | 3 |
| Danemark | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 5 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Roger Belusa
- Connexions Sociétés
